Interventional Cardiology Industry Research Report 2024

Interventional Cardiology Industry Research Report 2024


Summary

Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
According to APO Research, the global Interventional Cardiology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Interventional Cardiology is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Interventional Cardiology include Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S., BIOTRONIK SE and Co. KG, Bard Peripheral Vascular,Inc, TERUMO CORPORATION, KANEKA and OrbusNeich Medical, BV, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Interventional Cardiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Cardiology.
The report will help the Interventional Cardiology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Interventional Cardiology market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Cardiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular
MINVASYS S.A.S.
BIOTRONIK SE and Co. KG
Bard Peripheral Vascular,Inc
TERUMO CORPORATION
KANEKA
OrbusNeich Medical, BV
Cordis Cashel
Kimal Plc
Volcano Corporation
Siemens Medical Solutions USA, Inc
Lepu
MicroPort
Interventional Cardiology segment by Type

Cardiology Catheters
Guidewires
Balloon Catheters
Coronary Stents
Fractional Flow Reserve
Intravascular Ultrasound
Interventional Cardiology segment by Application

Hospitals
Clinics
Others
Interventional Cardiology Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interventional Cardiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Interventional Cardiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interventional Cardiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Interventional Cardiology manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Interventional Cardiology by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Interventional Cardiology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Interventional Cardiology Market Size (2019-2030) & (US$ Million)
2.2.2 Global Interventional Cardiology Sales (2019-2030)
2.2.3 Global Interventional Cardiology Market Average Price (2019-2030)
2.3 Interventional Cardiology by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Cardiology Catheters
2.3.3 Guidewires
2.3.4 Balloon Catheters
2.3.5 Coronary Stents
2.3.6 Fractional Flow Reserve
2.3.7 Intravascular Ultrasound
2.4 Interventional Cardiology by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hospitals
2.4.3 Clinics
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Interventional Cardiology Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Interventional Cardiology Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Interventional Cardiology Revenue of Manufacturers (2019-2024)
3.4 Global Interventional Cardiology Average Price by Manufacturers (2019-2024)
3.5 Global Interventional Cardiology Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Interventional Cardiology, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Interventional Cardiology, Product Type & Application
3.8 Global Manufacturers of Interventional Cardiology, Date of Enter into This Industry
3.9 Global Interventional Cardiology Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Medtronic, Inc.
4.1.1 Medtronic, Inc. Company Information
4.1.2 Medtronic, Inc. Business Overview
4.1.3 Medtronic, Inc. Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Medtronic, Inc. Interventional Cardiology Product Portfolio
4.1.5 Medtronic, Inc. Recent Developments
4.2 Boston Scientific Corporation
4.2.1 Boston Scientific Corporation Company Information
4.2.2 Boston Scientific Corporation Business Overview
4.2.3 Boston Scientific Corporation Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Boston Scientific Corporation Interventional Cardiology Product Portfolio
4.2.5 Boston Scientific Corporation Recent Developments
4.3 Abbott Vascular
4.3.1 Abbott Vascular Company Information
4.3.2 Abbott Vascular Business Overview
4.3.3 Abbott Vascular Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Abbott Vascular Interventional Cardiology Product Portfolio
4.3.5 Abbott Vascular Recent Developments
4.4 MINVASYS S.A.S.
4.4.1 MINVASYS S.A.S. Company Information
4.4.2 MINVASYS S.A.S. Business Overview
4.4.3 MINVASYS S.A.S. Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.4.4 MINVASYS S.A.S. Interventional Cardiology Product Portfolio
4.4.5 MINVASYS S.A.S. Recent Developments
4.5 BIOTRONIK SE and Co. KG
4.5.1 BIOTRONIK SE and Co. KG Company Information
4.5.2 BIOTRONIK SE and Co. KG Business Overview
4.5.3 BIOTRONIK SE and Co. KG Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.5.4 BIOTRONIK SE and Co. KG Interventional Cardiology Product Portfolio
4.5.5 BIOTRONIK SE and Co. KG Recent Developments
4.6 Bard Peripheral Vascular,Inc
4.6.1 Bard Peripheral Vascular,Inc Company Information
4.6.2 Bard Peripheral Vascular,Inc Business Overview
4.6.3 Bard Peripheral Vascular,Inc Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Bard Peripheral Vascular,Inc Interventional Cardiology Product Portfolio
4.6.5 Bard Peripheral Vascular,Inc Recent Developments
4.7 TERUMO CORPORATION
4.7.1 TERUMO CORPORATION Company Information
4.7.2 TERUMO CORPORATION Business Overview
4.7.3 TERUMO CORPORATION Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.7.4 TERUMO CORPORATION Interventional Cardiology Product Portfolio
4.7.5 TERUMO CORPORATION Recent Developments
4.8 KANEKA
4.8.1 KANEKA Company Information
4.8.2 KANEKA Business Overview
4.8.3 KANEKA Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.8.4 KANEKA Interventional Cardiology Product Portfolio
4.8.5 KANEKA Recent Developments
4.9 OrbusNeich Medical, BV
4.9.1 OrbusNeich Medical, BV Company Information
4.9.2 OrbusNeich Medical, BV Business Overview
4.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.9.4 OrbusNeich Medical, BV Interventional Cardiology Product Portfolio
4.9.5 OrbusNeich Medical, BV Recent Developments
4.10 Cordis Cashel
4.10.1 Cordis Cashel Company Information
4.10.2 Cordis Cashel Business Overview
4.10.3 Cordis Cashel Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Cordis Cashel Interventional Cardiology Product Portfolio
4.10.5 Cordis Cashel Recent Developments
4.11 Kimal Plc
4.11.1 Kimal Plc Company Information
4.11.2 Kimal Plc Business Overview
4.11.3 Kimal Plc Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Kimal Plc Interventional Cardiology Product Portfolio
4.11.5 Kimal Plc Recent Developments
4.12 Volcano Corporation
4.12.1 Volcano Corporation Company Information
4.12.2 Volcano Corporation Business Overview
4.12.3 Volcano Corporation Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Volcano Corporation Interventional Cardiology Product Portfolio
4.12.5 Volcano Corporation Recent Developments
4.13 Siemens Medical Solutions USA, Inc
4.13.1 Siemens Medical Solutions USA, Inc Company Information
4.13.2 Siemens Medical Solutions USA, Inc Business Overview
4.13.3 Siemens Medical Solutions USA, Inc Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Siemens Medical Solutions USA, Inc Interventional Cardiology Product Portfolio
4.13.5 Siemens Medical Solutions USA, Inc Recent Developments
4.14 Lepu
4.14.1 Lepu Company Information
4.14.2 Lepu Business Overview
4.14.3 Lepu Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.14.4 Lepu Interventional Cardiology Product Portfolio
4.14.5 Lepu Recent Developments
4.15 MicroPort
4.15.1 MicroPort Company Information
4.15.2 MicroPort Business Overview
4.15.3 MicroPort Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
4.15.4 MicroPort Interventional Cardiology Product Portfolio
4.15.5 MicroPort Recent Developments
5 Global Interventional Cardiology Market Scenario by Region
5.1 Global Interventional Cardiology Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Interventional Cardiology Sales by Region: 2019-2030
5.2.1 Global Interventional Cardiology Sales by Region: 2019-2024
5.2.2 Global Interventional Cardiology Sales by Region: 2025-2030
5.3 Global Interventional Cardiology Revenue by Region: 2019-2030
5.3.1 Global Interventional Cardiology Revenue by Region: 2019-2024
5.3.2 Global Interventional Cardiology Revenue by Region: 2025-2030
5.4 North America Interventional Cardiology Market Facts & Figures by Country
5.4.1 North America Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Interventional Cardiology Sales by Country (2019-2030)
5.4.3 North America Interventional Cardiology Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Interventional Cardiology Market Facts & Figures by Country
5.5.1 Europe Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Interventional Cardiology Sales by Country (2019-2030)
5.5.3 Europe Interventional Cardiology Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Interventional Cardiology Market Facts & Figures by Country
5.6.1 Asia Pacific Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Interventional Cardiology Sales by Country (2019-2030)
5.6.3 Asia Pacific Interventional Cardiology Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Interventional Cardiology Market Facts & Figures by Country
5.7.1 Latin America Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Interventional Cardiology Sales by Country (2019-2030)
5.7.3 Latin America Interventional Cardiology Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Interventional Cardiology Market Facts & Figures by Country
5.8.1 Middle East and Africa Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Interventional Cardiology Sales by Country (2019-2030)
5.8.3 Middle East and Africa Interventional Cardiology Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Interventional Cardiology Sales by Type (2019-2030)
6.1.1 Global Interventional Cardiology Sales by Type (2019-2030) & (K Units)
6.1.2 Global Interventional Cardiology Sales Market Share by Type (2019-2030)
6.2 Global Interventional Cardiology Revenue by Type (2019-2030)
6.2.1 Global Interventional Cardiology Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Interventional Cardiology Revenue Market Share by Type (2019-2030)
6.3 Global Interventional Cardiology Price by Type (2019-2030)
7 Segment by Application
7.1 Global Interventional Cardiology Sales by Application (2019-2030)
7.1.1 Global Interventional Cardiology Sales by Application (2019-2030) & (K Units)
7.1.2 Global Interventional Cardiology Sales Market Share by Application (2019-2030)
7.2 Global Interventional Cardiology Revenue by Application (2019-2030)
7.2.1 Global Interventional Cardiology Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Interventional Cardiology Revenue Market Share by Application (2019-2030)
7.3 Global Interventional Cardiology Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Interventional Cardiology Value Chain Analysis
8.1.1 Interventional Cardiology Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Interventional Cardiology Production Mode & Process
8.2 Interventional Cardiology Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Interventional Cardiology Distributors
8.2.3 Interventional Cardiology Customers
9 Global Interventional Cardiology Analyzing Market Dynamics
9.1 Interventional Cardiology Industry Trends
9.2 Interventional Cardiology Industry Drivers
9.3 Interventional Cardiology Industry Opportunities and Challenges
9.4 Interventional Cardiology Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings